top of page

Why IP Rights, Patents, and Trademarks Can Be Irrelevant, Especially in FinTech


Why IP Rights, Patents, and Trademarks Can Be Irrelevant, Especially in FinTech

In today’s guest post, we are excited to share insights from Yana Afanasieva, an expert in scaling compliance solutions for FinTech and crypto startups and founder of the FinTech Compliance Pro Certification. Here, Yana offers a fresh perspective on intellectual property (IP) rights, particularly within the dynamic and fast-evolving FinTech industry. This article sheds light on the limitations and complexities surrounding IP protection, and why many FinTech startups may find value in rethinking traditional views on IP.

The views and opinions expressed in this post belong solely to Yana Afanasieva and do not necessarily reflect those of Zenblock. Hope you all enjoy it!


IP Rights and FinTech: A Skeptical Perspective

I have consistently advised FinTech startups not to invest excessive time in registering trade names, domains, or logos, simply because they often have little to protect. The intellectual property (IP) registration system is largely designed to convince companies that they are safeguarding future secrets and profits. In reality, many businesses imitate one another's marketing, pricing strategies, and product ideas, and this is even before we consider the prevalence of open-source code.


Kinsella's Radical Take on IP

Stephan Kinsella's work significantly deepened my skepticism toward IP rights. Previously, I considered IP laws essential for protecting innovation. Kinsella, a former patent attorney and committed Bitcoiner, argues that intellectual property rights are not true "property rights" and are counterproductive.


How IP Creates Artificial Scarcity

Kinsella suggests that IP laws create an artificial scarcity of ideas by restricting their legal use. This restriction hampers the free flow of information and slows down technological progress. IP laws often establish monopolies that discourage further innovation by the original inventor and deter competition, resulting in higher prices and inefficient resource allocation.


A Lack of Empirical Evidence for IP's Role in Innovation

Kinsella questions the assumption that IP laws drive innovation and technological progress, arguing that empirical evidence for this is lacking. While compensating creators is important, granting monopoly rights is not the only way to do so. Market demand and voluntary transactions can reward creators without IP protections.


Real-World Examples of Innovation Without IP

History shows that innovation thrives even in the absence of IP protections. Many industries—such as fashion and cuisine—flourish without strong IP laws. Alternative incentives, including first-mover advantage and brand reputation, play a critical role in these sectors.


The Difference Between Ideas and Physical Property

Kinsella argues that ideas, unlike physical goods, are non-scarce resources. They can be shared infinitely without depletion, and attempting to apply scarcity through IP law leads to inefficiencies and economic distortions.


The Distinction Between Copying and Theft

When someone copies an idea, the original creator still possesses it—a sharp contrast to theft, which physically removes a good from its rightful owner. IP laws enforce monopolies that often benefit large corporations, transferring wealth from consumers and restricting access to innovations.


The Economic Burden of IP Law Enforcement

Enforcing IP laws involves significant legal costs and lengthy disputes. Determining what is "novel" or "original" can be subjective, leading to inconsistent rulings and protections for trivial ideas. These resources might be better spent on innovation and production rather than legal battles.


The Case of Pharmaceutical Patents

Initially, I questioned how Kinsella’s perspective applies to fields like pharmaceuticals, where R&D costs are high. Kinsella argues that patents in this industry are economically and ethically problematic:

  • Many medical breakthroughs emerge from government-funded research or university labs rather than private corporations.

  • Patent monopolies can lead companies to prioritize minor drug variations over significant research.

  • Patents enable monopoly pricing, restricting access to life-saving medications, especially in low-income populations.


What This Means for Generative AI and IP Concerns

I find Kinsella's ideas liberating, particularly as they relate to Generative AI and IP rights. New business models need to adapt to these shifts. Musicians and artists, for instance, often earn more from concerts and sponsorships than from copyrights. The notion that Scarlett Johansson “loses rights” when AI creates a similar voice is debatable.


Closing Thoughts

Kinsella’s insights challenge conventional beliefs about IP and innovation. They encourage us to reconsider how we foster innovation and support creators, especially in evolving industries like FinTech.


Special thanks to Yana Afanasieva for her permission to share this insightful article. You can follow her work and connect with her on LinkedIn here: https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=6887096593531621376 

Comments


bottom of page